Phase 1 Atrial Fibrillation Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
CancerAtrial FibrillationThrombosis+1 more
Massachusetts General Hospital165 enrolled1 locationNCT03830320
Recruiting
Phase 1Phase 2
Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Post-operative Atrial Fibrillation (POAF)
University of Michigan70 enrolled1 locationNCT05991700
Recruiting
Phase 1Phase 2
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
Atrial Fibrillation, Postoperative
Helios Cardio Inc.80 enrolled1 locationNCT06730828
Recruiting
Phase 1
Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease
Atrial Fibrillation
Assiut University100 enrolled1 locationNCT06556732
Recruiting
Phase 1
Synaptic Plasticity in the Epicardial Ganglionated Plexi
Atrial Fibrillation
University of Oklahoma90 enrolled1 locationNCT05034419